What does Cerebrolysin do? Benefits and evidence

An injectable pig brain mixture with mixed stroke, brain-injury and dementia evidence.

Also called: FPF-1070, Cerebrolysin concentrate.

Nootropic peptides · Porcine brain-derived peptide and amino-acid mixture · Evidence: Approved drug.

Cerebrolysin is an injectable mix of pig brain peptides and amino acids, with mixed recovery results and uncertain healthy-person benefits and long-term safety. Cochrane found no survival benefit after acute stroke and a possible rise in serious nonfatal harms. Some stroke and brain-injury trials report gains. National approvals exist in parts of Europe and Asia, but no FDA approval.

  • In Austria, doctors use it for patients after a stroke or head injury and for some kinds of dementia; it is not FDA approved. (Studied in a trial)
  • In stroke rehab trials, people's arm recovery was better with it, though the gain was smaller when trials were pooled. (Studied in a trial)
  • After brain injury, a trial found a small gain in daily function and thinking, but the evidence rests on two small trials. (Studied in a trial)
  • People report better mood, memory or sleep and less anxiety, though these goals lack strong clinical evidence. (Reported by users)

Uses in the sources

  • Nationally approved in Austria for support after stroke and head injury, and for Alzheimer-type or vascular dementia. (Clinician-published) (source)
  • Studied alongside stroke rehabilitation and standard TBI care; results differ across trials. (Studied in a trial) (source)
  • Reported online for memory, mood and recovery from past substance use; these goals lack convincing clinical evidence. (Reported by users) (source)

Related to Cerebrolysin

Sources

Sources checked: 2026-10-18.

Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.